Shotsy
US$ 23.66
arctic peptide semaglutide GLP-3 (RT) Weight-loss drug given green light
Description
The following figures were captured from Fella's official public pages on July 9, 2026
Extreme exhaustion that impairs daily function warrants evaluation
Your provider needs to write a new prescription for tirzepatide and may need to provide clinical justification if your insurance requires prior authorization
The FDA label includes pancreatitis as a warning
High medication costs remain a significant barrier, with the average price of GLP-1 drugs reaching USD 1,200 per month, making them inaccessible to many
GERD is a common condition with multiple contributing factors
